Table 2.
Traditional lipid profile, lipoprotein particle size and concentration, and vascular smooth muscle biomarkers in metabolically healthy obese PCOS (MHO-PCOS) girls and metabolically unhealthy obese (MUHO-PCOS) girls in the total cohort.
| Variables | MHO-PCOS (n=19) |
MUHO-PCOS (n=51) |
P |
Adjusted* P |
|---|---|---|---|---|
| Traditional Lipid Profile | ||||
| Total cholesterol (mg/dL) | 143.4 ± 6.6 | 160.2 ± 4.7 | 0.055 | NS |
| Triglyceride (mg/dL) | 114.5 ± 14.1 | 126.1 ± 8.3 | NS | NS |
| HDL (mg/dL) | 41.1 ± 2.7 | 40.4 ± 1.2 | NS | NS |
| LDL (mg/dL) | 79.4 ± 5.2 | 94.6 ± 4.2 | NS | NS |
| VLDL (mg/dL) | 22.4 ± 2.7 | 24.9 ± 1.6 | NS | NS |
| Non-HDL cholesterol (mg/dL) | 98.4 ± 11.9 | 121.7 ± 4.8 | 0.035 | 0.077 |
| Lipoprotein Particle Size | ||||
| HDL particle size (nm) | 8.9 ± 0.3 | 8.7 ± 0.3 | 0.026 | 0.046† |
| LDL particle size (nm) | 21.2 ± 0.8 | 20.7 ± 0.7 | 0.065 | NS |
| VLDL particle size (nm) | 50.5 ± 2.7 | 54.1 ± 1.8 | NS | NS |
| Lipoprotein Particle Concentration | ||||
| Large VLDL (nmol/L) | 2.5 ± 1.1 | 3.8 ± 0.6 | 0.027 | 0.006#† |
| Medium VLDL (nmol/L) | 17.9 ± 4.1 | 19.5 ± 1.9 | NS | NS |
| Small VLDL (nmol/L) | 21.9 ± 3.3 | 31.1 ± 2.3 | 0.039 | NS |
| IDL (nmol/L) | 21.4 ± 8.8 | 41.5 ± 6.2 | 0.021 | NS |
| Large LDL (nmol/L) | 286.3 ± 48.3 | 260.8 ± 22.8 | NS | NS |
| Medium-small LDL (nmol/L) | 93.6 ± 17.9 | 135.4 ± 11.1 | 0.055 | NS |
| Very small LDL (nmol/L) | 332.0 ± 54.1 | 520.1 ± 48.1 | 0.035 | 0.096 |
| Large HDL (mmol/L) | 4.9 ± 0.7 | 4.5 ± 0.5 | NS | NS |
| Medium HDL (mmol/L) | 4.1 ± 0.6 | 4.2 ± 0.5 | NS | NS |
| Small HDL (mmol/L) | 13.4 ± 1.0 | 16.7 ± 0.7 | 0.021 | 0.065 |
| Vascular Smooth Muscle Biomarkers | ||||
| ICAM-1 (ng/mL) | 172.2 ± 14.6 | 219.1 ± 17.3 | NS | NS |
| VCAM-1 (ng/mL) | 550.0 ± 75.8 | 615.2 ± 47.0 | NS | NS |
| E-selectin (ng/mL) | 37.5 ± 4.6 | 127.6 ± 45.5 | NS | NS |
Values are mean ± SEM.
P adjusted for race and Tanner stage.
indicates P <0.01 after adjusting for BMI in addition to race and Tanner stage.
indicates P <0.01 after adjusting for glucose tolerance status in addition to race and Tanner stage.
NS, not-significant.